Royalty Pharma Plc (RPRX)
61.41
+0.56
(+0.92%)
USD |
NASDAQ |
Aug 31, 16:00
61.40
-0.01
(-0.02%)
After-Hours: 20:00
Royalty Pharma Price : 61.41 for Aug. 31, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 31, 2026 | 60.80 | 61.68 | 60.39 | 61.41 | 3.895M |
| Aug 28, 2026 | 61.92 | 62.01 | 60.66 | 60.85 | 1.702M |
| Aug 27, 2026 | 61.42 | 62.35 | 61.01 | 61.92 | 2.094M |
| Aug 26, 2026 | 62.04 | 62.28 | 61.49 | 61.80 | 1.478M |
| Aug 25, 2026 | 61.33 | 62.46 | 60.87 | 62.07 | 1.705M |
| Aug 24, 2026 | 61.19 | 61.54 | 60.80 | 61.33 | 2.358M |
| Aug 21, 2026 | 60.53 | 61.60 | 60.37 | 61.31 | 2.325M |
| Aug 20, 2026 | 61.33 | 62.13 | 60.37 | 60.58 | 3.143M |
| Aug 19, 2026 | 60.12 | 61.80 | 59.75 | 61.73 | 3.257M |
| Aug 18, 2026 | 59.74 | 60.42 | 59.66 | 59.69 | 2.075M |
| Aug 17, 2026 | 58.36 | 59.49 | 58.18 | 59.45 | 2.360M |
| Aug 14, 2026 | 57.89 | 58.78 | 57.72 | 58.60 | 1.596M |
| Aug 13, 2026 | 59.50 | 59.58 | 57.94 | 58.56 | 2.517M |
| Aug 12, 2026 | 57.75 | 59.33 | 57.65 | 59.22 | 3.924M |
| Aug 11, 2026 | 58.04 | 58.63 | 57.76 | 57.79 | 2.394M |
| Aug 10, 2026 | 57.43 | 58.03 | 56.53 | 57.97 | 4.264M |
| Aug 07, 2026 | 57.44 | 57.66 | 56.60 | 56.77 | 4.159M |
| Aug 06, 2026 | 58.94 | 59.19 | 56.83 | 57.26 | 2.442M |
| Aug 05, 2026 | 59.53 | 59.63 | 57.41 | 57.75 | 3.537M |
| Aug 04, 2026 | 57.17 | 58.04 | 56.36 | 57.48 | 3.684M |
| Aug 03, 2026 | 58.26 | 58.29 | 56.97 | 57.17 | 2.748M |
| Jul 31, 2026 | 58.63 | 59.12 | 58.26 | 58.43 | 2.157M |
| Jul 30, 2026 | 58.45 | 59.67 | 58.45 | 59.02 | 2.846M |
| Jul 29, 2026 | 59.97 | 60.44 | 59.06 | 59.18 | 2.599M |
| Jul 28, 2026 | 58.91 | 60.08 | 58.91 | 59.97 | 3.139M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 162.13 |
| Johnson & Johnson | 265.85 |
| Merck & Co., Inc. | 147.76 |
| Viatris, Inc. | 16.51 |
| ANI Pharmaceuticals, Inc. | 73.25 |
Price Related Metrics
| PE Ratio | 32.69 |
| PS Ratio | 12.73 |
| Price to Book Value | 4.006 |
| Price to Free Cash Flow | 52.69 |
| Earnings Yield | 3.06% |
| Market Cap | 27.37B |
| Operating PE Ratio | 20.42 |
| Normalized PE Ratio | 34.77 |